Clinical, biochemical, immunogenetic paradigms of Covid-19 infection and their correlation with socio-demographic, etiological, pathogenetic, diagnostic, therapeutically and prognostically important factors to be included in guidelines

Project Details


The aim of the study is to identify socio-demographic, clinical, biochemical, molecular and immunological factors influencing human susceptibility to the virus, diagnosis of the disease, course, treatment results and post-infectious consequences. It is planned to recruit patients with various degrees of COVID-19 severity and also asymptomatic cases of SARS-CoV-2 infection. Data obtained in Latvian population will be important considering differences in spread of the disease and symptoms in various populations. The data will allow to develop clinical algorithms and guidelines, improve diagnosis and treatment efficacy and reduce lethality. Information obtained will allow us to perform comparative analysis with data from other countries and will allow to adapt World Health Organization’s guidelines in Latvia.
Effective start/end date1/07/2030/06/21


  • Latvian Council of Science: €497,580.00

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 10 - Reduced Inequalities


  • Course of the disease
  • prognostic factors
  • virus-specific markers
  • co-infections and conditions

Field of Science

  • 3.2 Clinical medicine

Smart Specialization Area

  • Biomedicine, medical technologies and biotechnology


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.